Researchers at Washington University School of Medicine have identified a potential new approach to treating glaucoma by inhibiting an enzyme that produces excessive nitric oxide, leading to cell damage. The study found that rats with elevated eye pressure lost less than 10% of their retinal ganglion cells when treated with the inhibitor.
Dr. Satcher addresses the American Chemical Society on building a better community health system, honoring black chemist Percy Julian's discovery of glaucoma treatment. He shares insights on opportunities and challenges for a balanced community health system.
Researchers have discovered a key role for the TIGR protein in non-hereditary forms of glaucoma, which may lead to novel diagnostic tools and treatments. The study found that exposure to steroid drugs or oxidative stress increased TIGR protein production, contributing to elevated intraocular pressure.
A groundbreaking study has identified a gene responsible for primary congenital glaucoma, a condition affecting 1 in 2,000 to 1 in 10,000 births. The discovery holds promise for early diagnosis and treatment, potentially preventing blindness, with the potential to be applied to adult-onset primary open angle glaucoma.
Scientists have discovered a new gene that causes Rieger syndrome, a rare disorder affecting tooth development and leading to glaucoma in 50% of cases. The RGS gene is similar in structure to genes found in fruit flies and mice, suggesting its role in human development.